IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,667 | +17.7% | 422 | 0.0% | 0.00% | – |
| Q1 2024 | $2,266 | +49.2% | 422 | 0.0% | 0.00% | – |
| Q4 2023 | $1,519 | +113.0% | 422 | 0.0% | 0.00% | – |
| Q3 2023 | $713 | -39.2% | 422 | 0.0% | 0.00% | – |
| Q2 2023 | $1,173 | +52.7% | 422 | 0.0% | 0.00% | – |
| Q1 2023 | $768 | +38300.0% | 422 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 422 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 422 | -31.6% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 617 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 617 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 617 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -33.3% | 617 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -40.0% | 617 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | – | 617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |